Ocular Toxicities Associated with ADCs and Other Cancer Therapies: Part 1 — Inside the Issue of Adverse Event Management

Featuring perspectives from Prof Rebecca A Dent, Dr Hans Lee, Dr Neel Pasricha and Dr Tiffany A Richards, including the following topics:

Introduction: The Patient Experience (0:00)

Managing Ocular Toxicities Associated with Antibody-Drug Conjugates and Other Cancer Therapies — Dr Pasricha (10:28)

Ocular Toxicities in Multiple Myeloma (45:33)

Ocular Toxicities in Breast Cancer (50:34)

CME information and select publications

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.